J Clin Endocrinol Metab 103(9):35033506 Mathiesen DS, Bagger JI, Bergmann NC, Lund A, Christensen MB, Vilsbll T et al (2019) The effects of dual GLP-1/GIP receptor agonism on glucagon secretion-a review
This step-by-step approach, called dose titration, helps make treatment easier to tolerate while still allowing the medication to work effectively
The 10mg vial provides sufficient material for extended experimental workflows and cost-efficient research programs
This is a normal physiological response as your body adapts
(PubMed) Lenzi A, Lombardo F, Sgro P, et al
Compared with untreated individuals, those receiving GLP-1 therapy showed lower levels of pro-inflammatory cytokines (IL-6, TNF-, IL-12), higher levels of IL-10, reduced expression of endothelial adhesion molecules (ICAM-1, VCAM-1), and decreased leukocyte rolling and adhesion along the vascular endothelium [15]